East Mediterr Health J by ALTMANN, Mathias et al.
Research article
1049
EMHJ – Vol. 24 No. 11 – 2018
Identifying hotspots of viral haemorrhagic fevers in the Eastern 
Mediterranean Region: perspectives for the Emerging and Dangerous 
Pathogens Laboratory Network
Mathias Altmann,1 Karen Nahapetyan 2 and Humayun Asghar 2
1Independent consultant epidemiologist, Paris, France. 2Department of Communicable Disease Prevention and Control, World Health Organization 
Regional Office for the Eastern Mediterranean, Cairo, Egypt (Correspondence to: Mathias Altmann; altmannmathias@yahoo.fr).
Introduction
Viral haemorrhagic fevers (VHFs) are among the most 
important pathogens that may cause public health emer-
gencies of international concern (PHEIC) as defined by 
the International health regulations (2005) (IHR) (1). It is esti-
mated that VHFs cause between 51 and 101 million (most-
ly dengue fever) cases each year, of which around 67 000 
are fatal (2). The emergence and re-emergence of VHFs is 
a growing concern worldwide. They are associated with 
the occurrence of major epidemics with high case fatality 
rates. In the past 2 decades, the Eastern Mediterranean 
Region has witnessed several major outbreaks of differ-
ent VHFs. In 2007, 13 countries of the Region reported 
VHF cases (3). Lack of timely laboratory diagnosis and 
functional epidemiological surveillance, inadequate in-
fection control practices at health care facilities, lack of 
specific vaccines and weak vector control programmes 
could result in prolonged outbreaks.
The Global Health Security agenda is an effort 
between the government of the United States of America, 
other nations, international organizations and public 
and private stakeholders to accelerate progress toward 
a world safe and secure from infectious disease threats 
and to promote global health security as an international 
priority. Developing and deploying novel diagnostics and 
strengthening laboratory systems are part of the strategy. 
Early confirmation of VHF diseases requires 
specialized laboratories with appropriate biosafety 
levels, a capacity for accurate diagnosis of emerging 
viral pathogens and a functional regional network 
of laboratories to provide a service that covers all the 
countries in the Region. The World Health Organization 
(WHO) Emerging and Dangerous Pathogens Laboratory 
Network (EDPLN) is made up of global and regional 
networks of high security human and veterinary 
diagnostic laboratories (4). The EDPLN was established 
to assist WHO in enhancing both the readiness and the 
response of countries for timely laboratory detection 
and management of outbreaks of novel, emerging and 
re-emerging pathogens and in facilitating the transfer of 
safe and appropriate diagnostic technologies, practices 
and training to laboratories in affected countries, as 
outlined in the IHR (2005) (1).
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The WHO Regional Office for Africa established 
its EDPLN networks in 2010 (5). Building the human 
and institutional capacities of designated laboratories 
for preparedness and response to emerging dangerous 
pathogens (EDP) (such as Ebola virus disease, MERS-CoV 
or Zika virus) is one of the priorities of the Member States 
of the Eastern Mediterranean Region. Currently, there are 
some laboratory networks in the Region operating under 
different clusters within the WHO Regional Office. These 
include the Poliomyelitis Laboratory Network (EPLN), 
Measles and Rubella Laboratory Network, Yellow Fever 
Laboratory Network, Japanese Encephalitis Laboratory 
Network, HPV Laboratory Network (LabNet), Rotavirus 
Laboratory Network, Invasive Bacterial Vaccine-
Preventable Diseases (IB-VPD) laboratory network. 
However, diagnosis capacities for EDP remain extremely 
limited in most Member States. The issue is further 
exacerbated by the lack of WHO collaborating centres or 
reference laboratories in the Region with the capacity for 
and experience of EDP testing that could provide support 
and technical assistance to other countries. Hence there 
is an urgent need to establish a functional EDPLN system 
in the Region, providing reliable, accurate and timely 
diagnosis at all levels.
The network will include national EDP reference 
laboratories among the 22 countries of the Region. 
It will serve for laboratory surveillance, detection of 
and response to EDP and as reference laboratories 
for confirmation of cases and capacity-building in 
all countries of the Region. Effective design of the 
laboratory network critically depends on the availability 
of information on the epidemiologic situation, patterns 
and hotspots of VHF in the Region. 
The main purpose of this study was to review the 
epidemiological situation in the Eastern Mediterranean 
Region vis-à-vis VHFs to obtain baseline epidemiological 
information for the establishment of the Emerging 
Dangerous Pathogen Laboratory Network.
Methods
Setting
The WHO’s Eastern Mediterranean Region comprises 22 
countries: Afghanistan, Bahrain, Djibouti, Egypt, Islamic 
Republic of Iran, Iraq, Jordan, Kuwait, Lebanon, Libya, 
Morocco, Oman, Pakistan, Palestine, Qatar, Saudi Arabia, 
Somalia, Sudan, Syrian Arab Republic, Tunisia, United 
Arab Emirates and Yemen.
Viral haemorrhagic fevers 
The present work does not address the exhaustive list of 
diseases which are diagnosed routinely: the target was 
biosafety levels 2 and 3 (BSL2/BSL3) diagnostic facilities. 
Viral haemorrhagic fevers served as a reference for the 
establishment of the EDPLN; they include Crimean–Con-
go haemorrhagic fever, dengue/dengue haemorrhagic fe-
ver, West Nile fever, Rift Valley fever, yellow fever, Hanta 
fever, Alkhurma haemorrhagic fever, tick-borne encepha-
litis and Ebola.
Literature review
A literature search was performed in PubMed, ProMED-
Mail and GIDEON databases using country name and 
disease/virus specific terms. Additional sources of infor-
mation included WHO and Centers for Disease Control 
and Prevention webpages. The analysis period was re-
stricted to 1995–2015. All information/studies older than 
1995 were excluded. Epidemiological information consid-
ered in this review included reported cases and deaths 
(including notable outbreaks), prevalence and seropreva-
lence studies among humans and/or accidental hosts and 
associated individual risk factors, vectors and reservoirs, 
environmental risk factors (e.g. flooding, drought) and 
geographical distribution (literature review available on 
request from the corresponding author). Data were ana-
lysed by country and by disease/virus. All available epide-
miological information considered above was reported. 
Particular attention was paid to the date of the report/
study, its location and its result (number of cases, sero-
prevalence/prevalence). 
Analysis
The analysis aimed at identifying “hotspots” of VHF in 
the Region in order to inform the establishment of ED-
PLN. To our knowledge, there is no standardized meth-
od that applies to this particular objective, therefore, for 
the purposes of this study, a simple working method was 
established. This method consisted in using 6 epidemio-
logical criteria (i.e. number of reported cases, number of 
reported deaths, prevalence in general population, prev-
alence in high–risk groups, prevalence in vectors and 
prevalence in reservoirs) to score each country.
Epidemiological criteria 
For reported number of cases and deaths, the total num-
ber for each pathogen was approximated by adding all re-
ported cases and deaths from the literature review. When 
numbers were approximated in the literature review (e.g. 
n > 500), the nearest rounded number was selected (e.g. 
n = 500). Outbreaks without a specified number of cases 
were not included in the calculation. Equine populations 
are not a reservoir for West Nile Fever viruses but rather 
an “end host”. As such, there were considered as human 
cases for the purposes of this study.
For the prevalence, estimates were separated between 
general population and high-risk groups among humans. 
Equine populations were considered as a high-risk 
group. Other high–risk groups included animal workers, 
military, people in care settings and sewage workers. The 
highest prevalence was selected if different estimates 
were available. This method does not aim to provide the 
true estimate but rather to compare countries with each 
other. Furthermore, calculation of a mean prevalence 
would need to weight each estimate by the total 
population, which was beyond the scope of this study. 
For vectors and reservoir, the highest estimate was 
selected as well. Vectors included ticks, mosquitoes and 
fleas. Reservoirs included livestock, birds, rodents, dogs, 
camels and other mammals.
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Cut-off values and score
The aim was to define a scoring system 
in order to compare countries on their 
VHF epidemiological criteria. First, we 
defined a cut-off value as the median val-
ue among all countries for each criterion 
and by pathogen. Then, the estimate for a 
criterion (number of cases or prevalence) 
was compared to this median value and a 
score was attributed. The scoring system 
was: 0 points when no data were available 
or the estimate was zero; 1 point when the 
estimate was greater than 0 but under the 
median value; 2 points when the estimate 
was equal to or greater than the medi-
an value. Finally, the total score for each 
country was calculated by combining the 
total score of the 6 criteria for all patho-
gens.
The 22 countries were divided into 4 
groups (very high, high, medium and low 
affected countries) according to their total 
score. We first calculated the median of 
the total score and the interquartile range. 
Then, we compared the total score of each 
country to the median and interquartile 
range values in order to classify each 
country into one of the 4 categories: low 
affected country when total score was 
between zero and the first quartile value; 
medium affected country when total 
score was greater than the first quartile 
value and under the median value; high 
affected country when total score was 
greater than the median value and under 
the third quartile value; and very high 
affected country when total score was 
equal or greater than the third quartile 
value.
Results
Reported cases and deaths
Total numbers and median of reported 
cases and deaths for VHFs during 1995–
2015 are summarized in Table 1. Human 
cases for at least 1 pathogen were reported 
in 13 (59%) countries. Considering equine 
cases, 14 (64%) countries reported VHF 
cases. Reported cases ranged from 2 for 
Alkhurma fever in Egypt to more than 
30 000 for dengue fever in Pakistan. While 
the highest number of actual reported cas-
es was for dengue fever, the VHFs which 
had the widest geographical distribution 
were Crimean–Congo haemorrhagic fe-
ver, dengue and West Nile fever with 8 
countries each. The median for reported 
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haemorrhagic fever to 1454 for yellow fe-
ver. The total reported deaths ranged from 
8 in the Islamic Republic of Iran to 720 in 
Yemen. While Crimean–Congo haemor-
rhagic fever had the widest geographical 
distribution among countries, dengue 
was responsible for the greatest number 
of deaths: the number of reported deaths 
ranged from 3 Crimean–Congo haemor-
rhagic fever cases in Egypt to more than 
500 dengue cases in Pakistan.
Prevalence in the general 
population and in high–risk 
groups
The highest VHF seroprevalence in the 
general population and in high–risk 
groups during 1995–2015 is summarized in 
Table 2. Only 7 countries (31.8%) reported 
data on seroprevalence for at least 1 path-
ogen in the general population. Seropreva-
lence ranged from 0% for Crimean–Congo 
haemorrhagic fever to 21.8% for dengue 
fever, both in Djibouti. Medians ranged 
from 2.1% for Rift Valley fever to 21.8% for 
dengue fever. Seroprevalence was most 
frequently reported for West Nile fever; 
seroprevalence was not reported at all for 
some diseases (yellow fever, Alkhurma, 
tick-borne encephalitis and Ebola). Twelve 
countries (54.5%) reported data on sero-
prevalence in high–risk groups for at least 
1 pathogen, ranging from 2.4% for Crime-
an–Congo haemorrhagic fever in Oman to 
81.8% for Rift Valley fever in Sudan, with a 
median of 36.0%.
Vectors and reservoirs
Highest and median prevalence of VHF 
among vectors (ticks, mosquitoes) and 
reservoirs (livestock, birds, rodents, cam-
els) are summarized in Table 3. Only 3 
(13.6%) countries reported a prevalence 
for vectors, Islamic Republic of Iran (28% 
for Crimean–Congo haemorrhagic fever 
in ticks), Oman (13% for Crimean–Congo 
haemorrhagic fever in ticks) and Egypt 
(1.7% for West Nile virus in ticks). Addition-
ally, 4 countries reported the presence of 
VHF viruses in vectors without prevalence 
estimates. The remaining 15 countries did 
not report the presence or prevalence of 
vectors. 
Eleven (50%) countries reported data 
on reservoirs for at least 1 pathogen. 
For Yemen, no prevalence was reported, 
however, as more than 9000 deaths 
due to Rift Valley fever were reported 
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attributed to this country. Distribution 
ranged from 1% for West Nile virus in 
birds in Tunisia and Crimean–Congo 
haemorrhagic fever in livestock in Egypt 
to 75% for Crimean–Congo haemorrhagic 
fever in livestock in Afghanistan. The 
median ranged from 3.6% for Hanta virus 
to 20.5% for Crimean–Congo haemorrhagic 
fever. 
Crimean–Congo haemorrhagic fever 
was also the most frequently reported 
VHF among the countries, followed by Rift 
Valley fever and West Nile fever.
Scoring
Scoring results for the 6 epidemiological 
criteria are presented in Table 4. Total scores 
ranged from 0 for Bahrain, Libya, Palestine 
and Qatar to 26 for Saudi Arabia. The me-
dian score was 6.0, with an inter-quartile 
range from 1.0 to 11.75. Countries above the 
third quartile were Afghanistan, Egypt, Is-
lamic Republic of Iran, Pakistan, Saudi Ara-
bia and Sudan. Scores were calculated for 
63 (47.7%) of the 132 possible scores (6 × 22). 
The information most frequently missing 
was prevalence in both the general popula-
tion and in vectors, followed by prevalence 
in the reservoir. 
Using the scoring results on prevalence 
in humans and accidental hosts, countries 
were divided into 3 groups (high, medium 
and low relative prevalence). Countries with 
the highest relative prevalence for VHFs 
were Afghanistan, Djibouti, Egypt, Islamic 
Republic of Iran and Saudi Arabia. Countries 
with a medium relative prevalence for VHFs 
were Kuwait, Morocco, Oman, Pakistan, 
Sudan and Tunisia. Low affected countries 
were Bahrain, Iraq, Jordan, Lebanon, Libya, 
Palestine, Qatar, Somalia, Syria, United Arab 
Emirates and Yemen. 
Using the scoring results on prevalence 
in vectors and reservoirs, countries were 
divided into 3 groups (high, medium and 
low relative prevalence). Countries with 
the highest relative prevalence for VHFs 
in vectors/reservoirs were Egypt, Islamic 
Republic of Iran, Oman, Morocco and Saudi 
Arabia. Countries with a medium relative 
prevalence for VHFs in vectors/reservoirs 
were Afghanistan, Kuwait, Lebanon, 
Somalia Sudan, Syrian Arab Republic, 
Tunisia and Yemen. Countries with a low 
relative prevalence for VHFs in vectors/
reservoirs were Bahrain, Djibouti, Iraq, 
Jordan, Libya, Pakistan, Palestine, Qatar and 

















































































































































































































































































































































































































Our scoring results for VHFs allowed for dividing the 
22 countries from the East Mediterranean Region into 4 
groups (very high, high, medium and low affected coun-
tries). This global classification should help in prioritiz-
ing countries to be part of EDPLN. Nevertheless, each 
country had specific epidemiological patterns of VHF: 
while some countries were more affected by outbreaks, 
others had higher prevalence among risk groups, vectors 
or reservoirs. Accordingly, specific recommendations for 
outbreak investigations, surveillance and research are ad-
dressed.
Outbreak investigation
Likewise, for the scoring results on disease burden only 
(reported cases and deaths), countries were divided into 
4 groups. Each country had specific epidemiological pat-
terns of VHF. However, some pathogens were common 
between neighbouring countries. Cross-border investi-
gations should be particularly relevant for the following 
borders and pathogens:
 · Afghanistan, Islamic Republic of Iran and Pakistan 
borders: dengue fever and Crimean–Congo haemor-
rhagic fever;
 · Saudi Arabia and Yemen border: Rift Valley fever, 
dengue fever, Alkhurma haemorrhagic fever;
 · United Arab Emirates and Oman border: Crimean–
Congo haemorrhagic fever.
By providing laboratory capacity, EDPLN should 
enhance the possibility of increasing outbreak 
investigations. This support might include mobile 
laboratory capacities, including mobile BSL3 and the 
rapid diagnostic test (RDT) for field investigation of 
VHF outbreaks. The EDPLN should play a critical role 
in building a roster for a multidisciplinary team during 
outbreak investigations. The One Health initiative should 
be used as an opportunity for this purpose as well as the 
IHR (1). 
Emerging dangerous pathogens surveillance
By providing laboratory capacity, EDPLN should enhance 
the ability of countries to strengthen and/or set up labora-
tory surveillance in the general population and high–risk 
groups. According to the scoring results on prevalence in 
humans and accidental hosts, countries were divided into 
3 groups (high, medium and low relative prevalence). By 
providing laboratory capacities, EDPLN should also en-
hance the capacity of countries to strengthen and/or set 
up laboratory surveillance in animals. According to the 
scoring results on prevalence in vectors and reservoirs, 


















Afghanistan 6 2 2 7 0 2 19
Bahrain 0 0 0 0 0 0 0
Djibouti 2 0 5 1 0 0 8
Egypt 4 2 2 5 2 1 16
Iraq 2 2 0 0 0 0 4
Islamic Republic of Iran 3 1 3 3 2 4 16
Jordan 0 0 0 1 0 0 1
Kuwait 0 0 0 3 0 2 5
Lebanon 0 0 0 0 1 0 1
Libya 0 0 0 0 0 0 0
Morocco 2 2 2 0 1 3 10
Oman 2 3 0 2 2 2 11
Pakistan 6 4 0 2 0 0 12
Palestine 0 0 0 0 0 0 0
Qatar 0 0 0 0 0 0 0
Saudi Arabia 6 5 2 8 2 3 26
Somalia 3 2 0 0 0 2 7
Sudan 9 9 0 2 0 1 21
Syrian Arab Republic 0 0 0 0 1 0 1
Tunisia 2 2 2 2 0 1 9
United Arab Emirates 1 2 0 1 0 0 4
Yemen 3 3 0 0 0 2 8
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countries were divided into 3 groups (high, medium and 
low relative prevalence). The role of livestock (Crimean–
Congo haemorrhagic fever, Rift Valley fever, rickettsia 
and leptospirosis) and camels (MERS-CoV) as reservoirs 
for many VHFs makes livestock/camels an important 
focus and target for EDP surveillance. Since VHFs are 
almost always zoonotic, there is a need for focused sur-
veillance at the human, livestock and wildlife interface. 
It is essential for EDPLN to conduct further serological 
studies in collaboration with the animal health sector. 
Environmental investigation (e.g. water and food storage) 
may also help in public health decisions.
There is a need for differential diagnoses for VHFs. 
An appropriate algorithm and syndromic approach needs 
to be developed and harmonized within the EDPLN. An 
example would be the development of multiplex panels 
for screening and confirmation of suspected VHF cases 
using the Integrated Disease Surveillance and Response 
case definition. A referral system for confirmation has 
been proposed for AFRO EDPLN (5). 
Research
Information was scarce for many pathogens and coun-
tries, highlighting the need to perform operational re-
search on VHFs. Discrepancies were noticed between 
criteria inside countries. For example, Afghanistan had 
a large number of cases but information on vectors and 
reservoirs was weak. This is an indication of the poten-
tial for research. Recommendations on research include 
performing, in order of priority:<list>
 · prevalence studies in humans: for Crimean–Congo 
haemorrhagic fever (Iraq), for dengue fever and Rift 
Valley fever (Somalia); 
 · vector and reservoir studies for Crimean–Congo 
haemorrhagic fever (Afghanistan, Iraq, Pakistan), 
dengue fever (Afghanistan, Pakistan, Somalia, Yem-
en), West Nile Fever (Afghanistan, Pakistan) and Rift 
Valley fever (Yemen). 
Limitations
Analyses were based on available information, mainly 
from PubMed, ProMED-Mail and GIDEON databas-
es. These 3 sources of information are reliable and well 
known. While ProMED-mail and GIDEON are robust 
and sensitive mechanisms for the discovery of emerging 
disease outbreaks involving humans, animals and plants 
around the world (6), PubMed is a robust and specific 
mechanism for publishing data on surveillance and re-
search. Other databases were not used. Some data might 
not have been captured because they were not included 
among our data sources. Embase is somewhat similar to 
PubMed, however, it has more of a European focus and 
concentrates to a greater degree on the pharmacological 
literature. The Cochrane Library is a collection of databas-
es that bring together in one place research on the effec-
tiveness of health care treatments and interventions, so it 
was not appropriate for our study. Furthermore, by using 
few key words for searching, we remained very sensitive 
among the 3 databases we used. It is worthwhile noting 
that reliability of data was prioritized for this work, and 
that unreliable data sources might lead to erroneous es-
timates. 
Unpublished surveillance data from ministries 
of health were not included. While they would have 
improved the completeness of our study for some 
countries, it would have been difficult to combine both 
data sources (published and unpublished) without 
possible double counting.
Another challenge was to summarize each criterion. 
Although outbreaks were reported, the number of cases 
and deaths were not always reported. Numbers were 
reported from different sources with probable double 
counting. Some numbers were simple estimations while 
others were confirmed cases. For this study, confirmed 
cases were used when available. For prevalence, general 
population and high–risk groups, as well as vectors and 
reservoirs were separated because they should provide 2 
distinct indicators. Information on the general population 
and among vectors was so scarce that a single criterion 
might have been an option. The challenge was finally to 
find the right balance between having a single criterion 
that might not capture all available information and too 
many criteria that might not inform our objective.
Another issue was the methodology for scoring each 
criterion. Although today there are a number of published 
tools to guide the process of setting priorities, only a few 
publications describe the methodology in sufficient detail 
and transparency to allow reproducibility or adaptation in 
other settings (7–9). The concept of hotspots in infectious 
disease epidemiology varies widely in current research, 
and may include aspects, such as incidence or prevalence, 
transmission efficiency or risk, or probability of disease 
emergence (10). For our study, the objective was neither to 
assess socioeconomic level nor health system capacity, but 
rather the disease burden and its potential transmission 
in order to compare multiple diseases between multiple 
countries. Therefore, we used a working method for the 
specific purposes of this study. The aim was to compare 
countries according to available information rather than 
trying to provide absolute and precise estimates. The 
median value of available information for each pathogen 
was used with this aim. This method has the advantage 
of being simple and reproducible. Other methods include 
the use of spatiotemporal techniques and geographic 
information systems (11–13). But the objective in those 
studies is to assess factors responsible for outbreak 
emergence and spread in a specific area. Furthermore, it 
is rare to have a complete databases with geopositioning 
of all cases, such as the one for Crimean–Congo 
haemorrhagic fever (14). Compared to the method used 
in Germany (15,16), our methodology did not weight each 
criterion: the availability of the data alone weighted each 
criterion. Alternatively, weighting would require a Delphi 
process, which was not possible for this study.
Conclusion
The results of this study highlighted hotspots for VHFs 
in the Region, including Afghanistan, Egypt, Islamic 
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ف عىل مواقع اخلطر للحميات النزفية الفريوسية يف إقليم رشق املتوسط: وجهات نظر نحو إنشاء شبكة خمتربات  التعرُّ
لكشف مسببات األمراض املستجدة واخلطرية 
ماثياس ألتامن، كارين هنابيتيان، مهايون أصغر
اخلالصة
ة واملعاودة للظهور قلًقا متزايًدا يف مجيع أرجاء العامل. إذ تسبب أوبئة ضخمة يصل تعداد املصابني  يات النزفية الفريوسية املستجدَّ اخللفية: تثري احُلمَّ
هبا كل عام إىل 51 -101 مليون شخص، ينتهي ما يقرب من 67 ألًفا منهم باملوت. ويف عام 2007، أبلغ 13 بلًدا من إقليم رشق املتوسط عن 
يات النزفية الفريوسية. حاالت مصابة باحُلمَّ
املعلومات  عىل  للحصول  الفريوسية  النزفية  يات  للُحمَّ اإلقليم  يف  الوبائية  األوضاع  مراجعة  يف  الدراسة  هذه  من  الرئييس  اهلدف  متثل  األهداف: 
األساسية الوبائية لتأسيس شبكة خمتربات مسببات األمراض املستجدة اخلطرية. 
تضمنتها  التي  البيانات  وشملت   ،GIDEONو  ProMED-Mailو  PubMed البيانات  قواعد  يف  شاماًل  بحًثا  الباحثون  أجرى  البحث:  طرق 
التقارير عبء املرض )عدد احلاالت وعدد الوفيات التي ُأْبِلغ عنها( ومعدل االنتشار بني البرش )يف جممل السكان ويف املجموعات املعرضة ملخاطر 
عالية(، ونواقل األمراض ومستودعاهتا. واستخدم الباحثون طريقة لتعيني الدرجات، لتقسيم البلدان إىل 4 جمموعات )بلدان مرتفعة الترضر جًدا، 
وبلدان مرتفعة الترضر، وبلدان متوسطة الترضر، وبلدان خفيفة الترضر(.
النتائج: كانت البلدان املرتفعة الترضر جًدا هي: أفغانستان ومرص ومجهورية إيران اإلسالمية واململكة العربية السعودية والسودان. وكانت البلدان 
املرتفعة الترضر هي: جيبويت واملغرب وُعاَمن وباكستان وتونس واليمن. وكانت البلدان املتوسطة الترضر هي: العراق والصومال واإلمارات العربية 
املتحدة. وكانت البلدان اخلفيفة الترضر هي: البحرين واألردن ولبنان وليبيا وفلسطني وقطر واجلمهورية العربية السورية.
االستنتاجات: تساهم هذه الدراسة يف وضع البلدان وفق أولويتها لتكون جزًءا من شبكة خمتربات مسببات األمراض املستجدة اخلطرية، ويف معاجلة 
االحتياجات املحددة ذات الصلة بعمليات استقصاء األوبئة، وترصدها، وبحثها.
Republic of Iran, Saudi Arabia and Sudan. This global 
classification should help in prioritizing countries to be 
part of EDPLN. Nonetheless, each country had specific 
epidemiological patterns of VHFs. Accordingly, recom-
mendations for outbreak investigations, surveillance and 
research were separately addressed.
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Identification des foyers de transmission de fièvres hémorragiques virales dans la 
Région de la Méditerranée orientale : perspectives pour le Réseau des laboratoires 
travaillant sur les agents pathogènes émergents et dangereux (EDPLN)
Résumé
Contexte : L’émergence et la réémergence des fièvres hémorragiques virales (FHV) est une préoccupation mondiale 
croissante. Ces fièvres sont associées à la survenue d’épidémies majeures. On estime qu’entre 51 et 101 millions de cas 
surviennent chaque année, dont environ 67 000 sont mortels. En 2007, 13 pays de la Région de la Méditerranée orientale 
ont rapporté des cas de FHV.
Objectifs : Le principal objectif de la présente étude était d’examiner la situation épidémiologique dans la Région eu 
égard aux FHV afin d’obtenir des informations épidémiologiques de base pour la mise en place du Réseau des laboratoires 
travaillant sur les agents pathogènes émergents et dangereux (EDPLN). 
Méthodes : Une recherche documentaire a été réalisée sur les bases de données PubMed, ProMED-Mail et GIDEON. Les 
données fournies incluaient la charge de morbidité (cas et décès signalés), la prévalence humaine (population générale, 
groupes à haut risque), les vecteurs et les réservoirs. Une méthode de notation a été utilisée pour diviser les pays en 
quatre groupes (pays très gravement touchés, gravement touchés, moyennement touchés et faiblement touchés).
Résultats : Les pays très gravement touchés étaient l’Afghanistan, l’Arabie saoudite, l’Égypte, la République islamique 
d’Iran et le Soudan. Les pays gravement touchés étaient Djibouti, le Maroc, Oman, le Pakistan, la Tunisie et le Yémen. 
Les pays moyennement touchés étaient les Émirats arabes unis, l’Iraq et la Somalie. Les pays faiblement touchés étaient 
Bahreïn, la Jordanie, le Liban, la Libye, la Palestine, le Qatar et la République arabe syrienne. 
Conclusions : La présente étude aide à classer par ordre de priorité les pays destinés à faire partie de l’EDPLN et à répondre 
à des besoins spécifiques en lien avec les investigations des flambées, la surveillance et la recherche.
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